Vanderklish, Peter W.

Reversal of Disease-Related Pathologies in the Fragile X Mouse Model by Selective Activation of GABA B Receptors with Arbaclofen

Henderson, C., Wijetunge, L., Kinoshita, M. N., Shumway, M., Hammond, R. S., Postma, F. R., Brynczka, C., Rush, R., Thomas, A., Paylor, R., et al. (2012) · Science Translational Medicine

Genetics and Neurodevelopmental DisordersNeuroscience and Neuropharmacology Research

Cited by 249

Marking synaptic activity in dendritic spines with a calpain substrate exhibiting fluorescence resonance energy transfer

Vanderklish, P. W., Krushel, L. A., Holst, B. H., Gally, J. A., Crossin, K. L., & Edelman, G. M. (2000) · Proceedings of the National Academy of Sciences

Calpain Protease Function and RegulationNeuroscience and Neuropharmacology Research

Cited by 163

Early Postnatal Plasticity in Neocortex of Fmr1 Knockout Mice

Desai, N. S., Casimiro, T. M., Gruber, S. M., & Vanderklish, P. W. (2006) · Journal of Neurophysiology

Genetics and Neurodevelopmental DisordersNeuroscience and Neuropharmacology Research

Cited by 113

Synaptic actin stabilization protein loss in Down syndrome and Alzheimer disease

Lauterborn, J. C., Cox, C. D., Chan, S. W., Vanderklish, P. W., Lynch, G., & Gall, C. M. (2020) · Brain Pathology

Alzheimer's disease research and treatmentsDown syndrome and intellectual disability research

Cited by 43